aminopropionitrile and oltipraz

aminopropionitrile has been researched along with oltipraz in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, X; Du, X; Huang, X; Le, S; Li, R; Luo, J; Song, Y; Wang, D; Wang, H; Wu, J; Wu, L; Ye, P1

Other Studies

1 other study(ies) available for aminopropionitrile and oltipraz

ArticleYear
Oltipraz, the activator of nuclear factor erythroid 2-related factor 2 (Nrf2), protects against the formation of BAPN-induced aneurysms and dissection of the thoracic aorta in mice by inhibiting activation of the ROS-mediated NLRP3 inflammasome.
    European journal of pharmacology, 2022, Dec-05, Volume: 936

    Topics: Aminopropionitrile; Aneurysm; Animals; Aorta, Thoracic; Inflammasomes; Mice; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species

2022
chemdatabank.com